Concepedia

Aria Vaishnavi

AV

Statistics

Publications

8

Citations

1.5K

H-Index

8

Active since

2013

Affiliations

University of Colorado Denver(Current)

University of Colorado Cancer Center

Foundation Medicine (United States)

Huntsman Cancer Institute

Array BioPharma (United States)

Aria Vaishnavi is an author at University of Colorado Denver specializing in medicine, molecular oncology, and oncology.

ORCID

Publications per year

2013–2022

8

Publications

8

Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer

Aria Vaishnavi, Marzia Capelletti, Anh T. Le et al. · Nature Medicine · 2013 · 602 citations · Full text

, , +12

An Oncogenic <i>NTRK</i> Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101

Robert C. Doebele, Lara E. Davis, Aria Vaishnavi et al. · Cancer Discovery · 2015 · 387 citations · Full text

, , +17

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer

Gorjan Hrustanovic, Victor Olivas, Evangelos Pazarentzos et al. · Nature Medicine · 2015 · 277 citations · Full text

, , +16

Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer

Kurtis D. Davies, Sakshi Mahale, David P. Astling et al. · PLoS ONE · 2013 · 135 citations · Full text

, , +17

EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases

Aria Vaishnavi, Laura Schubert, Uwe Rix et al. · Cancer Research · 2017 · 83 citations · Full text

, , +17

1–5 of 8